# Oxonian Ventures

> Oxonian Ventures is a Palo Alto early-stage venture fund that backs one specific kind of founder - University of Oxford alumni. Started in 2016 as the Oxford Angel Fund and rebranded in 2024, it has put money into 30-plus companies across biotech, fintech, AI and materials science, pooling capital from more than 90 Oxford-educated investors to write pre-seed, seed and Series A checks into ventures built by fellow Oxonians.

- **Founded:** 2016
- **Headquarters:** Palo Alto, California, United States
- **Founders:** Paula Skokowski (Co-Founder & General Partner), Neil Wolff (Founder & General Partner), Cameron Turner (General Partner)
- **Team size:** ~39 (including the wider investor network); 4 General Partners lead the fund
- **Products:** Oxford Alumni Venture Fund III, Oxford Alumni Venture Funds I & II, Investor syndicate / LP network, Founder application pathway
- **Notable:** Invested in 30+ early-stage companies since 2016, Built a network of 90+ accredited Oxford-alumni investors, Announced first close of $15M Fund III in July 2024

## Products & services

- **Oxford Alumni Venture Fund III** — The fund's third vehicle, targeting $15M for pre-seed, seed and Series A investments in Oxford alumni-founded companies. First close announced July 2024.
- **Oxford Alumni Venture Funds I & II** — Earlier funds through which Oxonian Ventures built a portfolio of 30+ early-stage companies since 2016.
- **Investor syndicate / LP network** — A network of 90+ accredited Oxford-alumni investors who pool capital and expertise into the funds.
- **Founder application pathway** — Oxford alumni founders apply for investment via Gust; accredited alumni investors join via an investor interest form.

## Achievements

- Invested in 30+ early-stage companies since 2016
- Built a network of 90+ accredited Oxford-alumni investors
- Announced first close of $15M Fund III in July 2024
- Portfolio exits including DocuVision (acquired by OneTrust, 2020), Going Merry (acquired by Earnest, 2021) and Rainmakers (acquired by Hirewell, 2022)
- Recruited veteran healthcare investor Heather Preston (ex-NEA, TPG Biotech, JPMorgan Partners) as General Partner in 2025

## Latest updates

- **2025-02** — Heather Preston, a senior healthcare venture investor, joined as General Partner to lead biotech and healthcare investing.
- **2024-07** — First close announced for the $15M Oxford Alumni Venture Fund III, focused on pre-seed, seed and Series A.
- **2024-07** — Rebranded from Oxford Angel Fund to Oxonian Ventures to reflect a broader, more institutional venture focus.

## Links

- Website: https://oxonianventures.com
- LinkedIn: https://www.linkedin.com/company/oxonian-ventures

---

Profile page: https://yespress.io/oxonian-ventures
Published by YesPress — https://yespress.io
Last updated: 2026-08-15